Business context and reporting period
Arbe Robotics Ltd. filed this Form 6-K for September 2026. The filing reports an underwritten registered direct offering announced on September 25, 2026; closing was anticipated on or about September 28, 2026, but this filing does not confirm that it closed.
Key financial and offering terms
- Offering: 833,334 ordinary shares at $0.60 each and pre-funded warrants to purchase up to 24,166,666 ordinary shares, offered at $0.5999 each. The warrants have a $0.0001 exercise price, are immediately exercisable, and may be exercised cashlessly.
- Gross proceeds: Approximately $15.0 million, before underwriting discounts, commissions, and offering expenses.
- Disclosed costs: Underwriting commissions and discounts of 6.0% of gross proceeds, plus $125,000 in expense reimbursement. Other offering expenses are not specified. The filing does not provide a clear net-proceeds figure.
- Use of proceeds: Working capital and general corporate purposes, including scaling operations for commercial opportunities, potential expansion into defense and counter-drone markets, and possible strategic M&A.
The filing provides no revenue, profit, cash flow, margin, debt, or current liquidity figures. It is an offering report, not a financial-results report.
Material changes and potential investor impact
- The securities represent up to 25 million ordinary shares in total when the pre-funded warrants are exercised, creating potential dilution. The filing does not provide the share count needed to quantify dilution as a percentage.
- Warrant exercises are subject to beneficial-ownership limits, generally 4.99% or 9.99%, with specified provisions for changing the limit.
- For 90 days after closing, the company agreed not to issue or announce certain additional equity or equity-linked securities, subject to exceptions.
Outlook, risks, and unusual items
Management identified a recently announced selection of Arbe radar technology for an L3 passenger-vehicle program at a large automotive group, and intended expansion into defense and counter-drone markets, as commercial opportunities the proceeds may support. The filing gives no forecast, expected revenue contribution, timing, or assurance that these opportunities or potential M&A will materialize. The offering price, dilution, warrant terms, execution of the stated plans, and the unconfirmed closing are key considerations.
Important facts to verify
- Whether the offering closed, and the final securities issued and proceeds received.
- Net proceeds after all commissions and offering expenses, and the company’s planned allocation of funds.
- The post-offering share count and resulting dilution, including the effect of any warrant exercises.
- Milestones, commercial terms, and expected financial contribution of the L3 vehicle program and any defense or counter-drone initiatives.